Small Lymphocytic Lymphoma (SLL)

>

CURE’s small lymphocytic lymphoma (SLL) page is a go-to resource for oncology news and updates in the world of SLL. Here, readers will find cancer articles, videos, podcasts, and more with expert insight into the latest treatments and research in small lymphocytic lymphoma (SLL).

Latest News

Image of Linda.
Teaching, Writing, Healing: The Intersections of My Cancer Journey

May 24th 2025

Fifteen years after being diagnosed with small lymphocytic lymphoma, I’ve found healing and meaning in the work I love and the life I’m grateful to live.

illustration of linda.
The Burst of Spring: Reflection for Those Living with Cancer

April 23rd 2025

Illustration of woman with light brown hair.
You Need Tough Skin With Cancer

February 5th 2025

Illustration of blood cells.
Brukinsa May Improve Efficacy Versus Imbruvica in R/R CLL and SLL

January 28th 2025

Illustration of woman with red hair.
Always Bring a Second Set of Ears to Your Oncology Checkup!

January 13th 2025

More News

FDA Approves Venclexta-Gazyva Combo as Frontline Treatment for CLL/SLL

FDA Approves Venclexta-Gazyva Combo as Frontline Treatment for CLL/SLL

OncLive Staff
May 15th 2019

The Food and Drug Administration has approved the combination use of Venclexta plus Gazyva for the frontline treatment of patients with chronic lymphocytic leukemia or small lymphocytic lymphoma.

2018 FDA Advancements in Small Lymphocytic Leukemia

2018 FDA Advancements in Small Lymphocytic Leukemia

Brielle Benyon
November 29th 2018

Take a look at the FDA’s decisions for the treatment of SLL that happened this year.

Imbruvica Yields Favorable Safety Outcomes in Two Types of Lymphomas

Imbruvica Yields Favorable Safety Outcomes in Two Types of Lymphomas

Katie Kosko
November 12th 2018

Imbruvica (ibrutinib) is a safe treatment for patients with chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL) and mantle cell lymphoma (MCL), according to a pooled analysis of four clinical trials.

FDA Approves Copiktra for Two Types of Blood Cancer

FDA Approves Copiktra for Two Types of Blood Cancer

Brielle Benyon
September 25th 2018

The drug was approved for adults with chronic lymphocytic leukemia and small lymphocytic lymphoma. And was granted an accelerated approval for follicular lymphoma.

<12